$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | M | 33.67 | 20,000 | 673,400 | 0 | |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | M | 33.67 | 20,000 | 673,400 | 0 | |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Sell | S | 79.80 | 521 | 41,577 | 6,332 | 6.9 K to 6.3 K (-7.60 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Sell | S | 79.80 | 521 | 41,577 | 6,332 | 6.9 K to 6.3 K (-7.60 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Sell | S | 78.88 | 3,000 | 236,650 | 6,853 | 9.9 K to 6.9 K (-30.45 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Sell | S | 78.88 | 3,000 | 236,650 | 6,853 | 9.9 K to 6.9 K (-30.45 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Buy | M | 27.75 | 3,521 | 97,708 | 9,853 | 6.3 K to 9.9 K (+55.61 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Buy | M | 27.75 | 3,521 | 97,708 | 9,853 | 6.3 K to 9.9 K (+55.61 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Sell | S | 82.25 | 510 | 41,945 | 6,332 | 6.8 K to 6.3 K (-7.45 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Sell | S | 82.25 | 510 | 41,945 | 6,332 | 6.8 K to 6.3 K (-7.45 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Sell | S | 81.70 | 14,490 | 1,183,887 | 6,842 | 21.3 K to 6.8 K (-67.93 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Sell | S | 81.70 | 14,490 | 1,183,887 | 6,842 | 21.3 K to 6.8 K (-67.93 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Sell | S | 82.11 | 11,479 | 942,572 | 21,332 | 32.8 K to 21.3 K (-34.99 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Sell | S | 82.11 | 11,479 | 942,572 | 21,332 | 32.8 K to 21.3 K (-34.99 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Buy | M | 27.75 | 6,479 | 179,792 | 32,811 | 26.3 K to 32.8 K (+24.61 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Buy | M | 27.75 | 6,479 | 179,792 | 32,811 | 26.3 K to 32.8 K (+24.61 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Buy | M | 33.67 | 20,000 | 673,400 | 26,332 | 6.3 K to 26.3 K (+315.86 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Buy | M | 33.67 | 20,000 | 673,400 | 26,332 | 6.3 K to 26.3 K (+315.86 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 26.01 | 10,000 | 260,100 | 0 | |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 26.01 | 10,000 | 260,100 | 0 | |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 79.57 | 693 | 55,142 | 67,619 | 68.3 K to 67.6 K (-1.01 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 79.57 | 693 | 55,142 | 67,619 | 68.3 K to 67.6 K (-1.01 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 78.80 | 9,307 | 733,417 | 68,312 | 77.6 K to 68.3 K (-11.99 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 78.80 | 9,307 | 733,417 | 68,312 | 77.6 K to 68.3 K (-11.99 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 26.01 | 10,000 | 260,100 | 77,619 | 67.6 K to 77.6 K (+14.79 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 26.01 | 10,000 | 260,100 | 77,619 | 67.6 K to 77.6 K (+14.79 %) |
| Feb 25 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Sell | S | 86.51 | 783 | 67,736 | 31,575 | 32.4 K to 31.6 K (-2.42 %) |
| Feb 25 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Payment of Exercise | F | 83.34 | 2,904 | 242,019 | 21,595 | 24.5 K to 21.6 K (-11.85 %) |
| Feb 25 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Payment of Exercise | F | 83.34 | 3,492 | 291,023 | 335,479 | 339 K to 335.5 K (-1.03 %) |
| Feb 25 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Payment of Exercise | F | 83.34 | 3,720 | 310,025 | 34,676 | 38.4 K to 34.7 K (-9.69 %) |
| Feb 25 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Payment of Exercise | F | 83.34 | 12,890 | 1,074,253 | 55,138 | 68 K to 55.1 K (-18.95 %) |
| Feb 25 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Payment of Exercise | F | 83.34 | 3,320 | 276,689 | 36,358 | 39.7 K to 36.4 K (-8.37 %) |
| Feb 25 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Payment of Exercise | F | 83.34 | 2,489 | 207,433 | 36,077 | 38.6 K to 36.1 K (-6.45 %) |
| Feb 25 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Payment of Exercise | F | 83.34 | 2,106 | 175,514 | 17,512 | 19.6 K to 17.5 K (-10.74 %) |
| Feb 25 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Payment of Exercise | F | 83.34 | 4,345 | 362,112 | 43,722 | 48.1 K to 43.7 K (-9.04 %) |
| Feb 22 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Option Exercise | M | 22.98 | 1,817 | 41,755 | 13,183 | |
| Feb 22 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Option Exercise | M | 17.18 | 18,750 | 322,125 | 0 | |
| Feb 22 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 77.57 | 3,817 | 296,087 | 17,032 | 20.8 K to 17 K (-18.31 %) |
| Feb 22 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 86.40 | 750 | 64,796 | 20,849 | 21.6 K to 20.8 K (-3.47 %) |
| Feb 22 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 85.47 | 1,067 | 91,192 | 21,599 | 22.7 K to 21.6 K (-4.71 %) |
| Feb 22 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Buy | M | 22.98 | 1,817 | 41,755 | 22,666 | 20.8 K to 22.7 K (+8.72 %) |
| Feb 22 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 83.50 | 3,271 | 273,119 | 20,849 | 24.1 K to 20.8 K (-13.56 %) |
| Feb 22 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 82.74 | 15,479 | 1,280,705 | 24,120 | 39.6 K to 24.1 K (-39.09 %) |
| Feb 22 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Buy | M | 17.18 | 18,750 | 322,125 | 39,599 | 20.8 K to 39.6 K (+89.93 %) |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Sell | S | 83.73 | 619 | 51,831 | 34,888 | 35.5 K to 34.9 K (-1.74 %) |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Sell | S | 83.03 | 2,889 | 239,878 | 35,507 | 38.4 K to 35.5 K (-7.52 %) |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 27.00 | 257 | 6,939 | 22,881 | |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 938 | 29,191 | 25,897 | |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 27.00 | 257 | 6,939 | 25,320 | 25.1 K to 25.3 K (+1.03 %) |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 938 | 29,191 | 25,063 | 24.1 K to 25.1 K (+3.89 %) |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Option Exercise | M | 27.48 | 2,800 | 76,944 | 46,453 | |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Option Exercise | M | 27.00 | 1,400 | 37,800 | 19,167 | |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Option Exercise | M | 31.98 | 1,500 | 47,970 | 78,667 | |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Sell | S | 83.55 | 3,616 | 302,125 | 35,678 | 39.3 K to 35.7 K (-9.20 %) |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Sell | S | 82.93 | 6,084 | 504,536 | 39,294 | 45.4 K to 39.3 K (-13.41 %) |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Buy | M | 27.48 | 2,800 | 76,944 | 45,378 | 42.6 K to 45.4 K (+6.58 %) |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Buy | M | 27.00 | 1,400 | 37,800 | 42,578 | 41.2 K to 42.6 K (+3.40 %) |
| Feb 21 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Buy | M | 31.98 | 1,500 | 47,970 | 41,178 | 39.7 K to 41.2 K (+3.78 %) |
| Feb 19 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 17.18 | 47,900 | 822,922 | 0 | |
| Feb 19 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 82.30 | 13,900 | 1,143,948 | 116,982 | 130.9 K to 117 K (-10.62 %) |
| Feb 19 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 81.46 | 34,000 | 2,769,667 | 130,882 | 164.9 K to 130.9 K (-20.62 %) |
| Feb 19 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 17.18 | 47,900 | 822,922 | 164,882 | 117 K to 164.9 K (+40.95 %) |
| Feb 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 22.98 | 10,000 | 229,800 | 26,424 | |
| Feb 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 26,471 | |
| Feb 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 81.48 | 4,065 | 331,211 | 48,067 | 52.1 K to 48.1 K (-7.80 %) |
| Feb 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 80.89 | 5,935 | 480,086 | 52,132 | 58.1 K to 52.1 K (-10.22 %) |
| Feb 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 22.98 | 10,000 | 229,800 | 58,067 | 48.1 K to 58.1 K (+20.80 %) |
| Feb 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 80.35 | 5,000 | 401,726 | 48,067 | 53.1 K to 48.1 K (-9.42 %) |
| Feb 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 17.18 | 5,000 | 85,900 | 53,067 | 48.1 K to 53.1 K (+10.40 %) |
| Feb 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 26,835 | |
| Feb 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 77.94 | 950 | 74,039 | 24,125 | 25.1 K to 24.1 K (-3.79 %) |
| Feb 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 77.19 | 2,050 | 158,234 | 25,075 | 27.1 K to 25.1 K (-7.56 %) |
| Feb 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 27,125 | 24.1 K to 27.1 K (+12.44 %) |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | S | 22.98 | 15,000 | 344,700 | 0 | |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 22.98 | 25,000 | 574,500 | 15,000 | |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 17.18 | 10,000 | 171,800 | 45,000 | |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 77.40 | 3,728 | 288,530 | 339,671 | 343.4 K to 339.7 K (-1.09 %) |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 76.72 | 19,080 | 1,463,842 | 343,399 | 362.5 K to 343.4 K (-5.26 %) |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 75.70 | 2,192 | 165,935 | 362,479 | 364.7 K to 362.5 K (-0.60 %) |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 17.18 | 10,000 | 171,800 | 364,671 | 354.7 K to 364.7 K (+2.82 %) |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 22.98 | 15,000 | 344,700 | 354,671 | 339.7 K to 354.7 K (+4.42 %) |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 76.61 | 200 | 15,322 | 339,671 | 339.9 K to 339.7 K (-0.06 %) |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 76.03 | 19,460 | 1,479,542 | 339,871 | 359.3 K to 339.9 K (-5.42 %) |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 75.19 | 5,340 | 401,520 | 359,331 | 364.7 K to 359.3 K (-1.46 %) |
| Feb 05 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 22.98 | 25,000 | 574,500 | 364,671 | 339.7 K to 364.7 K (+7.36 %) |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 29.34 | 25,000 | 733,500 | 0 | |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 29.34 | 25,000 | 733,500 | 25,000 | |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 75.94 | 155 | 11,770 | 339,671 | 339.8 K to 339.7 K (-0.05 %) |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 75.33 | 17,673 | 1,331,305 | 339,826 | 357.5 K to 339.8 K (-4.94 %) |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 74.28 | 5,364 | 398,463 | 357,499 | 362.9 K to 357.5 K (-1.48 %) |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 73.58 | 1,808 | 133,032 | 362,863 | 364.7 K to 362.9 K (-0.50 %) |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 29.34 | 25,000 | 733,500 | 364,671 | 339.7 K to 364.7 K (+7.36 %) |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 74.64 | 266 | 19,854 | 339,671 | 339.9 K to 339.7 K (-0.08 %) |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 74.20 | 11,418 | 847,210 | 339,937 | 351.4 K to 339.9 K (-3.25 %) |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 73.12 | 10,215 | 746,877 | 351,355 | 361.6 K to 351.4 K (-2.83 %) |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 72.01 | 3,101 | 223,289 | 361,570 | 364.7 K to 361.6 K (-0.85 %) |
| Feb 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 29.34 | 25,000 | 733,500 | 364,671 | 339.7 K to 364.7 K (+7.36 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | A | 72.52 | 27,740 | 2,011,705 | 27,740 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Grant | A | 0.00 | 4,020 | 0 | 48,067 | 44 K to 48.1 K (+9.13 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Option Exercise | A | 72.52 | 9,530 | 691,116 | 9,530 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Grant | A | 0.00 | 4,140 | 0 | 38,566 | 34.4 K to 38.6 K (+12.03 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Option Exercise | A | 72.52 | 8,100 | 587,412 | 8,100 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Grant | A | 0.00 | 3,520 | 0 | 20,849 | 17.3 K to 20.8 K (+20.31 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Option Exercise | A | 72.52 | 28,570 | 2,071,896 | 28,570 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Grant | A | 0.00 | 4,140 | 0 | 39,678 | 35.5 K to 39.7 K (+11.65 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | A | 72.52 | 75,610 | 5,483,237 | 75,610 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Grant | A | 0.00 | 10,960 | 0 | 68,028 | 57.1 K to 68 K (+19.21 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Option Exercise | A | 72.52 | 16,270 | 1,179,900 | 16,270 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Grant | A | 0.00 | 7,070 | 0 | 38,396 | 31.3 K to 38.4 K (+22.57 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | A | 72.52 | 9,530 | 691,116 | 9,530 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Grant | A | 0.00 | 4,140 | 0 | 24,125 | 20 K to 24.1 K (+20.72 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | A | 72.52 | 20,180 | 1,463,454 | 20,180 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Grant | A | 0.00 | 2,930 | 0 | 339,671 | 336.7 K to 339.7 K (+0.87 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 13,634 | 961,887 | 9,092,565 | 9.1 M to 9.1 M (-0.15 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 2,093 | 147,662 | 1,430,453 | 1.4 M to 1.4 M (-0.15 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 361 | 25,469 | 280,280 | 280.6 K to 280.3 K (-0.13 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 210 | 14,816 | 179,656 | 179.9 K to 179.7 K (-0.12 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 16 | 1,129 | 51,304 | 51.3 K to 51.3 K (-0.03 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 234 | 16,509 | 195,845 | 196.1 K to 195.8 K (-0.12 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 24,660 | 1,759,553 | 9,106,199 | 9.1 M to 9.1 M (-0.27 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 3,786 | 270,141 | 1,432,546 | 1.4 M to 1.4 M (-0.26 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 653 | 46,593 | 280,641 | 281.3 K to 280.6 K (-0.23 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 378 | 26,971 | 179,866 | 180.2 K to 179.9 K (-0.21 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 29 | 2,069 | 51,320 | 51.3 K to 51.3 K (-0.06 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 423 | 30,182 | 196,079 | 196.5 K to 196.1 K (-0.22 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 75,736 | 5,468,397 | 9,130,859 | 9.2 M to 9.1 M (-0.82 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 11,627 | 839,509 | 1,436,332 | 1.4 M to 1.4 M (-0.80 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 2,004 | 144,696 | 281,294 | 283.3 K to 281.3 K (-0.71 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 1,162 | 83,900 | 180,244 | 181.4 K to 180.2 K (-0.64 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 89 | 6,426 | 51,349 | 51.4 K to 51.3 K (-0.17 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 1,298 | 93,720 | 196,502 | 197.8 K to 196.5 K (-0.66 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 65,426 | 4,711,967 | 9,206,595 | 9.3 M to 9.2 M (-0.71 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 10,044 | 723,367 | 1,447,959 | 1.5 M to 1.4 M (-0.69 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 1,732 | 124,738 | 283,298 | 285 K to 283.3 K (-0.61 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 1,004 | 72,308 | 181,406 | 182.4 K to 181.4 K (-0.55 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 76 | 5,474 | 51,438 | 51.5 K to 51.4 K (-0.15 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 1,121 | 80,734 | 197,800 | 198.9 K to 197.8 K (-0.56 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 1,648 | 121,054 | 9,272,021 | 9.3 M to 9.3 M (-0.02 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 253 | 18,584 | 1,458,003 | 1.5 M to 1.5 M (-0.02 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 44 | 3,232 | 285,030 | 285.1 K to 285 K (-0.02 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 25 | 1,836 | 182,410 | 182.4 K to 182.4 K (-0.01 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 2 | 147 | 51,514 | 51.5 K to 51.5 K (0.00 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 28 | 2,057 | 198,921 | 198.9 K to 198.9 K (-0.01 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 29,260 | 2,063,313 | 9,273,669 | 9.3 M to 9.3 M (-0.31 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 4,492 | 316,760 | 1,458,256 | 1.5 M to 1.5 M (-0.31 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 774 | 54,580 | 285,074 | 285.8 K to 285.1 K (-0.27 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 450 | 31,732 | 182,435 | 182.9 K to 182.4 K (-0.25 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 34 | 2,398 | 51,516 | 51.6 K to 51.5 K (-0.07 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 502 | 35,399 | 198,949 | 199.5 K to 198.9 K (-0.25 %) |
| Jan 24 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Sell | S | 71.95 | 1,425 | 102,529 | 31,326 | 32.8 K to 31.3 K (-4.35 %) |